Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Inks Deal to Supply California with Spectrometry Systems

NEW YORK, Nov. 8 (GenomeWeb News) - PerkinElmer said today that it has signed agreements to provide California with tandem mass spectrometry systems to support the state's expanded newborn screening program.


According to PerkinElmer, it will provide California's contracted newborn screening laboratories with tandem mass spectrometry systems, reagent kits, and software. Additionally, a system will be installed at California's Genetic Disease Laboratory, which will analyze results from the screening labs and perform quality control oversight.


PerkinElmer also said it will provide the state's contracted newborn screening laboratories with 17-OHP assay kits for the screening of congenital adrenal hyperplasia. The company expects this system will be available for sale in late 2004 or early 2005.


Additional terms of the arrangements were not disclosed.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.